PegBio Co., Ltd. — Capital/Financing Update 2017

Jul 13, 2017

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [262 x 52] intentionally omitted <==

CMBC CAPITAL HOLDINGS LIMITED

(Incorporated in Bermuda with limited liability)

(Stock Code: 1141)

SUPPLEMENTAL ANNOUNCEMENT

Reference is made to the announcement of CMBC Capital Holdings Limited (the “ Company ”) dated 27 June 2017 (the “ Announcement ”) in relation to the Subscription of the Notes in the principal amount of US$30,000,000. Unless otherwise defined, capitalised terms used herein shall have the same meanings as those defined in the Announcement.

The Company would like to supplement that the name of each of the Issuer, the Holding Co. and the A-Share Listed Co. is Tasly (International) Healthcare Capital Company Limited, Tasly Holding Group Co., Ltd. and Tasly Pharmaceutical Group Co. Ltd. (天士力醫藥集團股 份有限公司), respectively.

By order of the Board CMBC Capital Holdings Limited Li Jinze Chairman

Hong Kong, 13 July 2017

As at the date of this announcement, the executive Directors is Mr. Li Jinze, the non-executive Directors are Mr. Ren Hailong and Mr. Liao Zhaohui, and the independent non-executive Directors are Mr. Lee, Cheuk Yin Dannis, Mr. Wu Bin and Mr. Wang Lihua.